OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Functional analysis of deubiquitylating enzymes in tumorigenesis and development
Ji Cheng, Jianping Guo, Brian J. North, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2019) Vol. 1872, Iss. 2, pp. 188312-188312
Closed Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Targeting the ubiquitination/deubiquitination process to regulate immune checkpoint pathways
Jiaxin Liu, Yicheng Cheng, Ming Zheng, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 57

Deubiquitylating Enzymes in Cancer and Immunity
Jiang Ren, Peng Yu, Sijia Liu, et al.
Advanced Science (2023) Vol. 10, Iss. 36
Open Access | Times Cited: 29

Role of Deubiquitinases in Human Cancers: Potential Targeted Therapy
Keng Po Lai, Jian Chen, William Ka Fai Tse
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2548-2548
Open Access | Times Cited: 51

Ubiquitin ligase CHIP regulates OTUD3 stability and suppresses tumour metastasis in lung cancer
Pengfei Zhang, Chaonan Li, Hongchang Li, et al.
Cell Death and Differentiation (2020) Vol. 27, Iss. 11, pp. 3177-3195
Open Access | Times Cited: 51

SNAIL1: Linking Tumor Metastasis to Immune Evasion
Xiaolong Tang, Xue Sui, Liang Weng, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 47

Targeting Ferroptosis by Ubiquitin System Enzymes: A Potential Therapeutic Strategy in Cancer
Meng Yu, Huiyan Sun, Yayun Li, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 14, pp. 5475-5488
Open Access | Times Cited: 32

Targeting CSC-related transcription factors by E3 ubiquitin ligases for cancer therapy
Weijia Wang, Wenjun Liu, Qiuli Chen, et al.
Seminars in Cancer Biology (2022) Vol. 87, pp. 84-97
Closed Access | Times Cited: 28

Ferroptosis and the ubiquitin-proteasome system: exploring treatment targets in cancer
Muhammad Azhar Ud Din, Yan Lin, Naijian Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7

The characteristics and roles of β‐TrCP1/2 in carcinogenesis
Yanli Bi, Danrui Cui, Xiufang Xiong, et al.
FEBS Journal (2020) Vol. 288, Iss. 11, pp. 3351-3374
Open Access | Times Cited: 49

Interplay between protein acetylation and ubiquitination controls MCL1 protein stability
Kouhei Shimizu, Min Gi, Shugo Suzuki, et al.
Cell Reports (2021) Vol. 37, Iss. 6, pp. 109988-109988
Open Access | Times Cited: 34

USP5-Beclin 1 axis overrides p53-dependent senescence and drives Kras-induced tumorigenicity
Juan Li, Yang Wang, Yue Luo, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 24

Ubiquitin-specific proteases in inflammatory bowel disease-related signalling pathway regulation
Rirong Chen, Xiaobai Pang, Li Li, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 23

Ubiquitin-specific protease 28: the decipherment of its dual roles in cancer development
Xiaoya Ren, Menglong Jiang, Peng Ding, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 14

Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy
Xian-Miao Li, Zhenyu Zhao, Yu Xiao, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 14

Exploring oncogenic roles and clinical significance of EZH2: focus on non-canonical activities
Michał Woźniak, Małgorzata Czyż
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access

Dysregulation of deubiquitinylases: a linchpin of gastrointestinal diseases
Lorena Ferino, Michael Naumann
Trends in Molecular Medicine (2025)
Open Access

USP13: A therapeutic target for combating tumorigenesis and antitumor therapy resistance
Lina Yi, Akezhouli Shahatiaili, Lin Zhang, et al.
International Journal of Biological Macromolecules (2025), pp. 140608-140608
Closed Access

The Deubiquitinase USP4 Stabilizes Twist1 Protein to Promote Lung Cancer Cell Stemness
Fengtian Li, Qingyong Hu, Tao He, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1582-1582
Open Access | Times Cited: 38

Deubiquitinase OTUD6A promotes proliferation of cancer cells via regulating Drp1 stability and mitochondrial fission
Le Shi, Jing Liu, Yunhua Peng, et al.
Molecular Oncology (2020) Vol. 14, Iss. 12, pp. 3169-3183
Open Access | Times Cited: 35

Deubiquitylases in developmental ubiquitin signaling and congenital diseases
Mohammed A. Basar, David B. Beck, Achim Werner
Cell Death and Differentiation (2020) Vol. 28, Iss. 2, pp. 538-556
Open Access | Times Cited: 35

USP29 coordinates MYC and HIF1α stabilization to promote tumor metabolism and progression
Rongfu Tu, Wenqian Kang, Mengjie Yang, et al.
Oncogene (2021) Vol. 40, Iss. 46, pp. 6417-6429
Closed Access | Times Cited: 30

Ubiquitination and deubiquitination in the regulation of N6-methyladenosine functional molecules
Yue Zhao, Jiaojiao Huang, Kexin Zhao, et al.
Journal of Molecular Medicine (2024) Vol. 102, Iss. 3, pp. 337-351
Closed Access | Times Cited: 4

Rolapitant treats lung cancer by targeting deubiquitinase OTUD3
Tongde Du, Quan Gu, Yonghui Zhang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top